• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液酸异羟肟酸:一种潜在的抗氧化剂及金属诱导的β-淀粉样蛋白聚集体抑制剂。

Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal-Induced β-Amyloid Aggregates.

作者信息

Yadav Rohan, Murthy Raghavendra Vasudeva, Kikkeri Raghavendra

机构信息

Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pashan, Pune 411008 (India).

出版信息

Chembiochem. 2015 Jul 6;16(10):1448-53. doi: 10.1002/cbic.201500162. Epub 2015 Jun 8.

DOI:10.1002/cbic.201500162
PMID:25944626
Abstract

Current methods for Alzheimer's treatment require a three-component system: metal chelators, antioxidants, and amyloid β (Aβ)-peptide-binding scaffolds. We report sialic acid (Sia) hydroxamate as a potential radical scavenger and metal chelator to inhibit Aβ aggregation. A cell viability assay revealed that Sia hydroxamate can protect HeLa and glioblastoma (LN229) cells from oxidative damage induced by the Fenton reaction. Sedimentation and turbidity assays showed profound protection of neuroblastoma SH-SY5Y cells from metal-induced Aβ aggregation and neural toxicity.

摘要

目前治疗阿尔茨海默病的方法需要一个三组分系统

金属螯合剂、抗氧化剂和淀粉样β(Aβ)肽结合支架。我们报告了唾液酸(Sia)异羟肟酸作为一种潜在的自由基清除剂和金属螯合剂,可抑制Aβ聚集。细胞活力测定表明,Sia异羟肟酸可以保护HeLa细胞和胶质母细胞瘤(LN229)细胞免受芬顿反应诱导的氧化损伤。沉降和浊度测定表明,神经母细胞瘤SH-SY5Y细胞能得到有效保护,免受金属诱导的Aβ聚集和神经毒性的影响。

相似文献

1
Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal-Induced β-Amyloid Aggregates.唾液酸异羟肟酸:一种潜在的抗氧化剂及金属诱导的β-淀粉样蛋白聚集体抑制剂。
Chembiochem. 2015 Jul 6;16(10):1448-53. doi: 10.1002/cbic.201500162. Epub 2015 Jun 8.
2
Two macrocyclic polyamines as modulators of metal-mediated Aβ40 aggregation.两种大环多胺作为金属介导的Aβ40聚集的调节剂。
Integr Biol (Camb). 2015 Jun;7(6):655-62. doi: 10.1039/c5ib00064e. Epub 2015 May 13.
3
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach.靶向阿尔茨海默病中的Nrf2/β-淀粉样蛋白联系:一种合理的方法。
ACS Chem Neurosci. 2017 Jul 19;8(7):1618-1627. doi: 10.1021/acschemneuro.7b00100. Epub 2017 Apr 25.
4
Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides.咖啡酸共轭淀粉样β蛋白C末端肽对淀粉样纤维形成和细胞毒性的抑制作用
Bioorg Med Chem Lett. 2016 Nov 15;26(22):5468-5471. doi: 10.1016/j.bmcl.2016.10.027. Epub 2016 Oct 12.
5
RTHLVFFARK-NH: A potent and selective modulator on Cu-mediated amyloid-β protein aggregation and cytotoxicity.RTHLVFFARK-NH:一种有效的、选择性的铜介导的淀粉样β蛋白聚集和细胞毒性调节剂。
J Inorg Biochem. 2018 Apr;181:56-64. doi: 10.1016/j.jinorgbio.2018.01.012. Epub 2018 Feb 2.
6
Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.具有胆碱能、β-淀粉样肽降低和金属螯合特性的多功能他克林-黄酮杂合体,用于治疗阿尔茨海默病。
Eur J Med Chem. 2013 Nov;69:632-46. doi: 10.1016/j.ejmech.2013.09.024. Epub 2013 Sep 21.
7
Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease.黄酮杂合体的半合成及生物评价作为潜在阿尔茨海默病治疗的多功能药物。
Bioorg Chem. 2020 Jul;100:103917. doi: 10.1016/j.bioorg.2020.103917. Epub 2020 May 12.
8
Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.新型他克林-(β-咔啉)杂合物作为治疗阿尔茨海默病多功能药物的设计、合成与评价
Bioorg Med Chem. 2014 Nov 1;22(21):6089-104. doi: 10.1016/j.bmc.2014.08.035. Epub 2014 Sep 15.
9
Unusual Cyclodextrin Derivatives as a New Avenue to Modulate Self- and Metal-Induced Aβ Aggregation.新型环糊精衍生物作为调节自身及金属诱导的Aβ聚集的新途径
Chemistry. 2015 Sep 28;21(40):14047-59. doi: 10.1002/chem.201502155. Epub 2015 Aug 18.
10
Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.8-羟基喹啉类作为治疗阿尔茨海默病的多靶标导向配体的生物学评价。
Curr Alzheimer Res. 2019;16(9):801-814. doi: 10.2174/1567205016666191010130351.

引用本文的文献

1
Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer's Disease Based on Novel Monoterpene-Derived Hydroxamic Acids.基于新型单萜衍生羟肟酸的阿尔茨海默病治疗有效多靶治疗平台的构建。
Int J Mol Sci. 2023 Jun 4;24(11):9743. doi: 10.3390/ijms24119743.